- Report
- February 2026
- 158 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 186 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 380 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 282 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 273 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 354 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 284 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 363 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 191 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 269 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 292 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 271 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 291 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 269 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 167 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 413 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 167 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 259 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 362 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 173 Pages
Global
From €5103EUR$5,850USD£4,447GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more